-
1 Comment
Trxade Group, Inc is currently in a long term uptrend where the price is trading 6.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.3.
Trxade Group, Inc's total revenue rose by 17.6% to $2M since the same quarter in the previous year.
Its net income has increased by 145.2% to $224K since the same quarter in the previous year.
Finally, its free cash flow grew by 99.7% to $-788 since the same quarter in the previous year.
Based on the above factors, Trxade Group, Inc gets an overall score of 5/5.
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US89846A2078 |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Beta | 2.17 |
|---|---|
| Target Price | 6.75 |
| Dividend Yield | 0.0% |
| PE Ratio | None |
| Market Cap | 13M |
TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for MEDS using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
